See more : Grupo Famsa, S.A.B. de C.V. (GFAMSAA.MX) Income Statement Analysis – Financial Results
Complete financial analysis of Kotra Industries Berhad (0002.KL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kotra Industries Berhad, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- FleetPartners Group Limited (FPR.AX) Income Statement Analysis – Financial Results
- Kensington Capital Acquisition Corp. V (KCGI) Income Statement Analysis – Financial Results
- Nuran Wireless Inc. (NUR.CN) Income Statement Analysis – Financial Results
- China PengFei Group Limited (3348.HK) Income Statement Analysis – Financial Results
- Zhejiang Wanma Co., Ltd. (002276.SZ) Income Statement Analysis – Financial Results
Kotra Industries Berhad (0002.KL)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.kotrapharma.com
About Kotra Industries Berhad
Kotra Industries Berhad, an investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia. It provides nutraceutical products, including various health supplement products under the Appeton brand for children, expectant mothers, and seniors. The company also offers various pharmaceutical products in the areas of pediatric care, anti-infective, gastroenterology, and dermatology under the Axcel brand; sterile antibiotic injectables under the Vaxcel brand; asthma control products under the Arite brand; fungal infection treatment products under the Creobic brand; and prevention of hair loss products under the Minox brand. In addition, it offers treatment of pain, such as headache, migraine, backache, toothache, aches due to cold and flu, muscular rheumatism, dysmenorrhea, and fever under the AxPain brand. The company was founded in 1982 and is headquartered in Malacca, Malaysia. Kotra Industries Berhad is a subsidiary of Piong Nam Kim Holdings Sdn. Bhd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 226.55M | 242.20M | 207.92M | 159.62M | 171.73M | 172.55M | 178.48M | 166.37M | 160.23M | 145.17M | 147.37M | 131.29M | 126.94M | 112.84M | 102.36M | 89.99M | 86.68M | 83.17M | 68.90M |
| Cost of Revenue | 60.27M | 62.50M | 51.08M | 40.52M | 42.20M | 47.01M | 52.37M | 46.22M | 47.46M | 40.60M | 43.25M | 39.99M | 41.44M | 38.54M | 33.41M | 31.86M | 27.16M | 28.55M | 23.42M |
| Gross Profit | 166.29M | 179.70M | 156.84M | 119.11M | 129.53M | 125.54M | 126.11M | 120.15M | 112.77M | 104.58M | 104.12M | 91.31M | 85.50M | 74.30M | 68.95M | 58.14M | 59.53M | 54.62M | 45.48M |
| Gross Profit Ratio | 73.40% | 74.19% | 75.43% | 74.62% | 75.43% | 72.76% | 70.66% | 72.22% | 70.38% | 72.04% | 70.65% | 69.54% | 67.35% | 65.84% | 67.36% | 64.60% | 68.67% | 65.68% | 66.01% |
| Research & Development | 0.00 | 0.00 | 10.00K | 224.00K | 237.00K | 68.00K | 414.00K | 407.00K | 641.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 28.84M | 31.23M | 25.61M | 22.68M | 30.41M | 30.00M | 33.82M | 34.24M | 30.47M | 37.04M | 28.95M | 25.16M | 25.14M | 27.08M | 21.55M | 22.40M | 22.67M | 0.00 | 0.00 |
| SG&A | 28.84M | 31.23M | 25.61M | 22.68M | 30.41M | 30.00M | 33.82M | 34.24M | 30.47M | 37.04M | 28.95M | 25.16M | 25.14M | 27.08M | 21.55M | 22.40M | 22.67M | 0.00 | 0.00 |
| Other Expenses | 88.05M | 0.00 | 0.00 | 0.00 | 24.00K | 60.00K | 89.00K | 89.00K | 89.00K | 89.00K | 89.00K | 87.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 116.89M | 118.90M | 102.63M | 93.21M | 104.09M | 104.07M | 107.07M | 104.82M | 100.37M | 101.99M | 92.92M | 80.92M | 76.55M | 71.69M | 55.63M | 48.55M | 51.60M | 45.43M | 36.04M |
| Cost & Expenses | 176.00M | 181.40M | 153.71M | 133.72M | 146.29M | 151.07M | 159.44M | 151.04M | 147.83M | 142.59M | 136.18M | 120.90M | 117.99M | 110.24M | 89.04M | 80.40M | 78.75M | 73.98M | 59.46M |
| Interest Income | 3.78M | 2.70M | 1.13M | 848.00K | 817.00K | 646.00K | 330.00K | 100.00K | 0.00 | 0.00 | 1.00K | 1.00K | 3.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 37.00K | 195.00K | 462.00K | 877.00K | 1.62M | 2.41M | 4.84M | 5.95M | 6.97M | 7.72M | 8.13M | 8.13M | 7.78M | 4.68M | 847.00K | 605.00K | 252.00K | 99.00K | 105.00K |
| Depreciation & Amortization | 14.27M | 14.62M | 14.70M | 15.88M | 15.96M | 13.97M | 13.50M | 13.42M | 13.29M | 12.31M | 11.50M | 10.94M | 10.64M | 5.73M | 2.94M | 2.58M | 2.52M | 2.33M | 2.07M |
| EBITDA | 70.78M | 80.89M | 73.44M | 43.03M | 43.50M | 37.74M | 34.24M | 31.89M | 28.10M | 21.20M | 25.39M | 22.90M | 19.59M | 8.33M | 16.27M | 12.18M | 10.48M | 11.55M | 11.51M |
| EBITDA Ratio | 31.24% | 33.54% | 34.68% | 27.11% | 25.74% | 21.88% | 18.86% | 18.78% | 17.35% | 14.43% | 17.05% | 17.26% | 15.43% | 7.39% | 15.89% | 13.53% | 12.06% | 13.86% | 16.70% |
| Operating Income | 49.39M | 66.59M | 57.38M | 27.36M | 28.22M | 23.77M | 20.13M | 17.80M | 14.52M | 8.65M | 13.63M | 11.72M | 8.95M | 2.61M | 13.32M | 9.60M | 7.93M | 9.19M | 9.44M |
| Operating Income Ratio | 21.80% | 27.49% | 27.60% | 17.14% | 16.44% | 13.78% | 11.28% | 10.70% | 9.06% | 5.96% | 9.25% | 8.93% | 7.05% | 2.31% | 13.01% | 10.67% | 9.15% | 11.05% | 13.69% |
| Total Other Income/Expenses | 7.08M | -514.00K | 895.00K | -1.09M | -2.30M | -2.41M | -4.23M | -5.27M | -6.65M | -2.32M | -7.86M | -7.89M | -7.78M | -4.68M | -847.00K | -605.00K | -252.00K | -99.00K | -105.00K |
| Income Before Tax | 56.47M | 66.08M | 58.28M | 26.27M | 25.93M | 21.36M | 15.90M | 12.52M | 7.87M | 1.18M | 5.77M | 3.83M | 1.18M | -2.08M | 12.47M | 8.99M | 7.68M | 9.09M | 9.33M |
| Income Before Tax Ratio | 24.93% | 27.28% | 28.03% | 16.46% | 15.10% | 12.38% | 8.91% | 7.53% | 4.91% | 0.81% | 3.91% | 2.92% | 0.93% | -1.84% | 12.18% | 9.98% | 8.86% | 10.93% | 13.54% |
| Income Tax Expense | 11.88M | 842.00K | -3.82M | 1.88M | -3.63M | -831.00K | 154.00K | 127.00K | 104.00K | 118.00K | 105.00K | 142.00K | 56.00K | 60.00K | 745.00K | -139.00K | -523.00K | -509.00K | -657.00K |
| Net Income | 44.60M | 65.23M | 62.10M | 24.39M | 29.56M | 22.20M | 15.75M | 12.40M | 7.76M | 1.06M | 5.66M | 3.69M | 1.12M | -2.14M | 11.72M | 9.12M | 8.20M | 9.60M | 9.99M |
| Net Income Ratio | 19.68% | 26.93% | 29.87% | 15.28% | 17.21% | 12.86% | 8.82% | 7.45% | 4.84% | 0.73% | 3.84% | 2.81% | 0.88% | -1.90% | 11.45% | 10.14% | 9.46% | 11.54% | 14.50% |
| EPS | 0.30 | 0.44 | 0.42 | 0.17 | 0.20 | 0.16 | 0.11 | 0.09 | 0.06 | 0.01 | 0.04 | 0.03 | 0.01 | -0.02 | 0.09 | 0.07 | 0.07 | 0.17 | 0.08 |
| EPS Diluted | 0.30 | 0.44 | 0.42 | 0.17 | 0.20 | 0.16 | 0.11 | 0.09 | 0.06 | 0.01 | 0.04 | 0.03 | 0.01 | -0.02 | 0.09 | 0.07 | 0.07 | 0.17 | 0.08 |
| Weighted Avg Shares Out | 148.30M | 148.00M | 147.97M | 147.55M | 144.72M | 139.36M | 141.88M | 132.67M | 132.38M | 132.06M | 131.94M | 127.78M | 123.81M | 123.81M | 123.81M | 123.81M | 123.79M | 56.25M | 123.73M |
| Weighted Avg Shares Out (Dil) | 148.30M | 148.04M | 148.04M | 147.63M | 146.33M | 141.73M | 141.88M | 140.68M | 138.14M | 139.38M | 137.01M | 129.38M | 123.88M | 123.81M | 123.81M | 123.81M | 123.79M | 57.76M | 124.67M |
Source: https://incomestatements.info
Category: Stock Reports